This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 23 Jun 2017  |  Europe  |  Market Research

    Growth Opportunities in the Western European IVD Industry, Forecast to 2021

    Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions

    Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the ...

    $4,950.00
  2. 22 Jun 2017  |  Asia Pacific  |  Market Research

    Malaysia, Singapore, and Indonesia Transformational Health Insights, 2017–2022

    Rapid Growth, Reforms, and Partnerships are Transforming Healthcare Systems in Malaysia, Singapore, and Indonesia

    Southeast Asia (SEA) is emerging as the gold mine for both local and international healthcare vendors. Within SEA, Malaysia, Singapore, and Indonesia still have unexplored and under-served markets providing boundless opportunities for healthcare vendors with innovative products and services. To be able to capitalize on the market, medical device ma...

    $1,500.00
  3. 20 Jun 2017  |  North America  |  Market Research

    Transformation and Growth Opportunities in the US Next-Generation Sequencing Informatics Market

    Pharmaceutical and Molecular Diagnostics Segments to Lead Revenue Growth

    Frost & Sullivan expects strong demand for commercial application-focused solutions to drive new investments in the development of tools and technologies, and will also result in consolidation of the US next-generation sequencing informatics market. Changing customer requirements and intense competition will drive the transformation. As companies l...

    $4,950.00
  4. 20 Apr 2017  |  Asia Pacific  |  Market Research

    The Philippines Transformational Healthcare Insights, 2016

    Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage

    The Philippines is a part of the Association of Southeast Asian Nations (ASEAN) community and one of the fastest growing healthcare markets in the region. With regard to healthcare, the Philippine Government has been looking at ways to achieve 100% enrolment to PhilHealth by 2020. One of the means is by mandating all Filipinos to enrol to PhilHealt...

    $1,500.00
  5. 23 Mar 2017  |  Asia Pacific  |  Market Research

    APAC Molecular Diagnostics Market, Forecast to 2021

    Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth

    The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identif...

    $4,950.00
  6. 14 Mar 2017  |  North America  |  Market Research

    Game-changing Strategies of Leading US Pharma Companies

    Focus on Beyond the Pill Services, Process Automation, and Patient Engagement across the Value Chain to Drive Growth

    The research service primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights into the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalization of key processes ac...

    $1,500.00
  7. 14 Feb 2017  |  North America  |  Market Research

    Trends, Opportunities, and Future of the Global Pharma Extractables and Leachables Testing Market

    Growing Prominence of Single Use Technologies and Biologics Market Driving Growth

    This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020. The pharma E&L testing market is ...

    $1,500.00
  8. 24 Jan 2017  |  Asia Pacific  |  Market Research

    Game-changing Strategies of APAC Pharma Companies

    Growing Focus on Specific Therapy Areas and Shift Towards Value-based Delivery Model Expected to Boost Pharma Market

    Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...

    $1,500.00
  9. 18 Jan 2017  |  North America  |  Market Research

    Disruptive Technologies and Game-changing Companies in the Global Pharmaceutical Cell Banking Market

    Proprietary CMO Cell Culture Technology Platforms are Disrupting the In-house-outsourced Balance of Cell Banking Services

    This market insight on the global cell banking market analyses disruptive technologies and provides details on game-changing companies. Biopharmaceutical companies are increasingly partnering with CMOs and CROs to store their proprietary cell lines and develop new ones. With increased collaborations, CMOs are coming up with niche and specific servi...

    $1,500.00
  10. 17 Jan 2017  |  Europe  |  Market Research

    Game-changing Strategies of European Pharma Companies

    Strong Focus on Digital Footprint and Beyond-the-pill Services Propel Companies to Innovate and Stay on the Growth Trajectory

    Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing European pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study...

    $1,500.00